← Leaderboards
Thomas A. Platts-Mills
University Of Virginia
$20,464,070
Attributed
$23,484,775
Total exposure
21
Grants
15
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$35,254,243 · 24
By mechanism
U19$8,524,008 · 5
R37$7,205,956 · 1
R01$7,142,006 · 1
U01$5,259,835 · 1
P01$4,942,316 · 2
M01$1,314,422 · 12
Top collaborators
- Peter W Heymann4 shared
- Scott Palmer Commins2 shared
- Jeffrey M Wilson1 shared
Most similar at University Of Virginia
Same institution · by research overlap
- Scott Palmer Commins$5,266,641
- Loren D Erickson$7,080,830
- Jeffrey M Wilson$1,437,558
Others in their field
Top investigators on “Asthma”
- James E. Gern · University Of Wisconsin-Madison$159,588,264
- William W. Busse · University Of Wisconsin Madison$104,093,792
- Scott T Weiss · University Of California, San Diego$98,211,117
- David T Mauger · Pennsylvania State Univ Hershey Med Ctr$79,309,576
- Fernando D Martinez · University Of Arizona$66,357,737
- Wanda Phipatanakul · Boston Children'S Hospital$50,505,446
Research focus
AsthmaAllergensAllergicAntibodiesSymptomsResponseInvestigationDesignSerumPyroglyphidAntigensVirginiaInflammationCytokineChildGrantAnaphylaxisImmune ResponseAdultCellsSourceEpidemiologyMeasurementPrevalence
Grant awards (79)
IgE antibodies to the mammalian oligosaccharide galactose-alpha-1, 3-galactose (alpha-gal): immunology, epidemiology and relevance to allergic and inflammatory disease$982,802
R37 · FY2025 · AI · contact PI
IgE antibodies to the mammalian oligosaccharide galactose-alpha-1, 3-galactose (alpha-gal): immunology, epidemiology and relevance to allergic and inflammatory disease$161,500
R37 · FY2025 · AI · contact PI
IgE antibodies to the mammalian oligosaccharide galactose-alpha-1, 3-galactose (alpha-gal): immunology, epidemiology and relevance to allergic and inflammatory disease$622,802
R37 · FY2024 · AI · contact PI
IgE antibodies to the mammalian oligosaccharide galactose-alpha-1, 3-galactose (alpha-gal): immunology, epidemiology and relevance to allergic and inflammatory disease$360,000
R37 · FY2024 · AI · contact PI
IgE antibodies to the mammalian oligosaccharide galactose-alpha-1, 3-galactose (alpha-gal): immunology, epidemiology and relevance to allergic and inflammatory disease$262,801
R37 · FY2024 · AI · contact PI
IgE antibodies to the mammalian oligosaccharide galactose-alpha-1, 3-galactose (alpha-gal): immunology, epidemiology and relevance to allergic and inflammatory disease$622,802
R37 · FY2023 · AI · contact PI
IgE antibodies to the mammalian oligosaccharide galactose-alpha-1, 3-galactose (alpha-gal): immunology, epidemiology and relevance to allergic and inflammatory disease$986,177
R37 · FY2022 · AI · contact PI
IgE antibodies to the mammalian oligosaccharide galactose-alpha-1, 3-galactose (alpha-gal): immunology, epidemiology and relevance to allergic and inflammatory disease$622,802
R37 · FY2021 · AI · contact PI
IgE antibodies to the mammalian oligosaccharide galactose-alpha-1, 3-galactose (alpha-gal): immunology, epidemiology and relevance to allergic and inflammatory disease$622,802
R37 · FY2020 · AI · contact PI
IgG4 and IgE antibodies to Cows Milk proteins in children with EosinophilicEsophagitis$201,875
R21 · FY2020 · AI · contact PI
IgE antibodies to the mammalian oligosaccharide galactose-alpha-1, 3-galactose (alpha-gal): immunology, epidemiology and relevance to allergic and inflammatory disease$129,200
R37 · FY2020 · AI · contact PI
IgE antibodies to the mammalian oligosaccharide galactose-alpha-1, 3-galactose (alpha-gal): immunology, epidemiology and relevance to allergic and inflammatory disease$445,840
R37 · FY2019 · AI · contact PI
IgG4 and IgE antibodies to Cows Milk proteins in children with EosinophilicEsophagitis$242,250
R21 · FY2019 · AI · contact PI
IgE antibodies to the mammalian oligosaccharide galactose-alpha-1, 3-galactose (alpha-gal): immunology, epidemiology and relevance to allergic and inflammatory disease$588,085
R37 · FY2018 · AI · contact PI
Dust Mite, Cockroach and Cat Allergens in Asthma$562,086
R01 · FY2017 · AI · contact PI
Dust Mite, Cockroach and Cat Allergens in Asthma$878,086
R01 · FY2016 · AI · contact PI
An Evaluation of Treatment with Omalizumab to Improve the Asthmatic Response to a$1,591,510
U01 · FY2015 · AI · contact PI
Dust Mite, Cockroach and Cat Allergens in Asthma$562,086
R01 · FY2015 · AI · contact PI
An Evaluation of Treatment with Omalizumab to Improve the Asthmatic Response to a$1,343,673
U01 · FY2014 · AI · contact PI
Dust Mite, Cockroach and Cat Allergens in Asthma$487,086
R01 · FY2014 · AI · contact PI
An Evaluation of Treatment with Omalizumab to Improve the Asthmatic Response to a$1,114,692
U01 · FY2013 · AI · contact PI
Dust Mite, Cockroach and Cat Allergens in Asthma$457,860
R01 · FY2013 · AI · contact PI
An Evaluation of Treatment with Omalizumab to Improve the Asthmatic Response to a$1,209,960
U01 · FY2012 · AI · contact PI
Dust Mite, Cockroach and Cat Allergens in Asthma$405,723
R01 · FY2012 · AI · contact PI
Dust Mite, Cockroach and Cat Allergens in Asthma$406,961
R01 · FY2011 · AI · contact PI
Delayed anaphylaxis to beef and pork: mechanisms and causes of a new food allergy$190,575
R21 · FY2011 · AI · contact PI
Asthma and Allergic Disease Center$1,335,425
U19 · FY2010 · AI · contact PI
Dust Mite, Cockroach and Cat Allergens in Asthma$409,439
R01 · FY2010 · AI · contact PI
Allergen Exposure, IgE responses and total IgE in relation to asthma in at risk$334,731
U19 · FY2010 · AI · contact PI
Delayed anaphylaxis to beef and pork: mechanisms and causes of a new food allergy$231,000
R21 · FY2010 · AI · contact PI
PROLONGED AVOIDANCE OF ENVIRONMENTAL FACTORS IN SEVERE ASTHMA$117,603
M01 · FY2010 · RR · contact PI
ASTHMA AND BREATHLESSNESS IN SCHOOL AGE CHILDREN$13,363
M01 · FY2010 · RR · contact PI
Asthma and Allergic Disease Center$1,000,636
U19 · FY2009 · AI · contact PI
Asthma and Allergic Disease Center$770,000
U19 · FY2009 · AI · contact PI
Dust Mite, Cockroach and Cat Allergens in Asthma$405,911
R01 · FY2009 · AI · contact PI
Allergen Exposure, IgE responses and total IgE in relation to asthma in at risk$250,722
U19 · FY2009 · AI · contact PI
PROLONGED AVOIDANCE OF ENVIRONMENTAL FACTORS IN SEVERE ASTHMA$32,172
M01 · FY2009 · RR · contact PI
ASTHMA AND BREATHLESSNESS IN SCHOOL AGE CHILDREN$1,951
M01 · FY2009 · RR · contact PI
Asthma and Allergic Disease Center$971,931
U19 · FY2008 · AI · contact PI
Dust Mite, Cockroach and Cat Allergens in Asthma$398,469
R01 · FY2008 · AI · contact PI
Allergen Exposure, IgE responses and total IgE in relation to asthma in at risk$243,518
U19 · FY2008 · AI · contact PI
PROLONGED AVOIDANCE OF ENVIRONMENTAL FACTORS IN SEVERE ASTHMA$108,581
M01 · FY2008 · RR · contact PI
ASTHMA AND BREATHLESSNESS IN SCHOOL AGE CHILDREN$4,310
M01 · FY2008 · RR · contact PI
Asthma and Allergic Disease Center$962,115
U19 · FY2007 · AI · contact PI
Allergen Exposure, IgE responses and total IgE in relation to asthma in at risk$240,883
U19 · FY2007 · AI · contact PI
PROLONGED AVOIDANCE OF ENVIRONMENTAL FACTORS IN SEVERE ASTHMA$192,432
M01 · FY2007 · RR · contact PI
ASTHMA AND BREATHLESSNESS IN SCHOOL AGE CHILDREN$16,036
M01 · FY2007 · RR · contact PI
Asthma and Allergic Disease Center$967,501
U19 · FY2006 · AI · contact PI
Dust Mite, Cockroach and Cat Allergens: Asthma$451,114
R01 · FY2006 · AI · contact PI
Allergen Exposure, IgE responses and total IgE in relation to asthma in at risk$240,752
U19 · FY2006 · AI · contact PI
PROLONGED AVOIDANCE OF ENVIRONMENTAL FACTORS IN SEVERE ASTHMA$101,095
M01 · FY2006 · RR · contact PI
UVA Asthma and Allergic Diseases Center$678,000
P01 · FY2005 · AI
Dust Mite, Cockroach and Cat Allergens: Asthma$448,512
R01 · FY2005 · AI
PROLONGED AVOIDANCE OF ENVIRONMENTAL FACTORS IN SEVERE ASTHMA$135,499
M01 · FY2005 · RR
EXPOSURE TO HOUSE DUST MITE ANTIGEN ON SKIN OF PATIENTS WITH ATOPIC DERMATITIS$27,573
M01 · FY2005 · RR
UVA Asthma and Allergic Diseases Center$1,148,800
P01 · FY2004 · AI
Dust Mite, Cockroach and Cat Allergens: Asthma$435,451
R01 · FY2004 · AI
Prolonged Avoidance Of Environmental Factors In Severe Asthma$214,129
M01 · FY2004 · RR
Exposure to house dust mite antigen on skin of patients with atopic dermatitis$99,338
M01 · FY2004 · RR
UVA Asthma and Allergic Diseases Center$1,115,549
P01 · FY2003 · AI
Dust Mite, Cockroach and Cat Allergens: Asthma$422,768
R01 · FY2003 · AI
UVA Asthma and Allergic Diseases Center$950,019
P01 · FY2002 · AI
Dust Mite, Cockroach and Cat Allergens: Asthma$410,454
R01 · FY2002 · AI
HOUSE DUST MITE ANTIGEN ON SKIN OF PATIENTS WITH ATOPIC DERMATITIS$48,533
M01 · FY2002 · RR
PROLONGED AVOIDANCE OF ENVIRONMENT FACTORS IN PATIENTS WITH ASTHMA$48,533
M01 · FY2002 · RR
Epidemiology and T cell response to cat allergen$0
P01 · FY2002 · AI
UVA Asthma and Allergic Diseases Center$1,049,948
P01 · FY2001 · AI
DUST MITE, COCKROACH AND CAT ALLERGENS IN ASTHMA$403,972
R37 · FY2001 · AI
HOUSE DUST MITE ANTIGEN ON SKIN OF PATIENTS WITH ATOPIC DERMATITIS$48,533
M01 · FY2001 · RR
PROLONGED AVOIDANCE OF ENVIRONMENT FACTORS IN PATIENTS WITH ASTHMA$48,533
M01 · FY2001 · RR
Epidemiology and T cell response to cat allergen$0
P01 · FY2001 · AI
ASTHMA AND ALLERGIC DISEASES CENTER$819,544
U19 · FY2000 · AI
DUST MITE, COCKROACH AND CAT ALLERGENS IN ASTHMA$394,371
R37 · FY2000 · AI
DEMONSTRATION/EDUCATION PROJECT--AVOIDENCE OF INDOOR ALLERGENS ASTHMA MANAGEMENT$193,125
U19 · FY2000 · AI
FACTORS INFLUENCING THE SEVERITY OF ASTHMA$193,125
U19 · FY2000 · AI
PROLONGED AVOIDANCE OF ENVIRONMENT FACTORS IN PATIENTS WITH ASTHMA$28,104
M01 · FY2000 · RR
HOUSE DUST MITE ANTIGEN ON SKIN OF PATIENTS WITH ATOPIC DERMATITIS$28,104
M01 · FY2000 · RR
HOUSE DUST MITE ANTIGEN ON SKIN OF PATIENTS WITH ATOPIC DERMATITIS$0
M01 · FY2000 · RR
PROLONGED AVOIDANCE OF ENVIRONMENT FACTORS IN PATIENTS WITH ASTHMA$0
M01 · FY2000 · RR